Recent findings from a comprehensive study conducted by researchers at the University of New South Wales in Sydney suggest that vaping may pose significant cancer risks, particularly for lung and oral cancers. This emerging evidence raises urgent questions about the safety of e-cigarettes, prompting calls for immediate regulatory intervention rather than waiting for definitive long-term studies.
Vaping: A Rising Health Concern
As vaping continues to gain popularity, particularly among younger demographics, the latest review highlights alarming biological changes associated with e-cigarette use. The study, published in the journal Carcinogenesis, assessed a vast array of research, including animal studies, human case reports, and laboratory investigations conducted between 2017 and 2025. Co-author Adjunct Professor Bernard Stewart emphasised that e-cigarette inhalation causes alterations in the cells and tissues of the oral cavity and lungs, indicating a potential pathway to cancer.
Despite the popularity of vaping, long-term data remains scarce, as e-cigarettes were only introduced in the early 2000s. The challenge is further complicated by the fact that many individuals who vape also smoke traditional cigarettes, obscuring the specific health impacts of vaping alone. Consequently, while the review did not quantify the cancer risk directly, it identified early warning signs, such as DNA damage and inflammation—key indicators of potential carcinogenesis.
Evidence of Harmful Effects
The researchers examined numerous case reports, including instances where dentists noted oral cancer in individuals who exclusively vaped and had no history of smoking. Additionally, they referenced animal studies, including one that found a higher incidence of lung tumours in mice exposed to e-cigarette vapour compared to their unexposed counterparts. While these findings do not directly translate to humans, they underscore the pressing need to consider the risks associated with vaping.
Lead author Associate Professor Freddy Sitas noted the parallels with the historical recognition of smoking as a health hazard. It took decades for the US Surgeon General to officially classify smoking as a cause of lung cancer. Sitas warned against delaying action on vaping in light of emerging evidence, suggesting that regulatory bodies should not wait for unequivocal proof of harm.
A Call for Regulatory Action
As the debate surrounding vaping intensifies, experts are urging policymakers to take the findings seriously. Calvin Cochran, a research fellow at the University of Otago, stressed the importance of addressing the potential dangers of vaping before they are dismissed or downplayed, as was the case with smoking.
The current data suggests that vaping should not be viewed as a safe alternative to smoking; rather, it may pose its own unique health risks. Although some researchers caution against equating the dangers of vaping with traditional smoking—due to differences in combustion products—there is a growing consensus that e-cigarettes may not be as innocuous as previously believed.
Professor Becky Freeman from the University of Sydney commented that this study is the first to assert an increased cancer risk for those who vape compared to non-vapers. She highlighted the need for stringent regulations that limit access to vaping products, especially for young people who have never smoked.
Why it Matters
The implications of this research are significant, particularly in the context of public health. As vaping becomes increasingly prevalent among youth, understanding its potential health risks is crucial. The evidence presented in this review underscores the necessity for proactive measures to protect vulnerable populations. Without timely and decisive regulatory action, we risk allowing a new generation to engage in behaviours that could have severe long-term health consequences. The call for comprehensive regulation and public awareness is not just a matter of health; it is a moral imperative to safeguard future generations from preventable diseases.
